Diener, H C <br/><br/>
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.  [electronic resource] 

 -  Cephalalgia : an international journal of headache  Jul 2010 
 - 804-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2982 
<br/><br/><label>Standard No.: </label>10.1177/0333102410364677  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Botulinum Toxins, Type A--therapeutic use<br/>Chronic Disease<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Migraine Disorders--drug therapy<br/>Neuromuscular Agents--therapeutic use<br/>Treatment Outcome<br/>Young Adult